GlassScriptPhysician profile
Cecilia Avalos
NPI 1306964788
$2,169.67
in general payments reported to CMS, 2019-2025
10 companies · $215 in 2025
The $215 reported for 2025 was more than what 76% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $201 · 2023: $1,238 · 2024: $408 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,860.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $858.50 | 2022-2025 | |
| Abbvie INC. | $650.61 | 2021-2025 | |
| Lumenis Be INC | $458.92 | 2023 | M22 |
| Merz North America, INC. | $102.11 | 2023 | Xeomin |
| Revance Therapeutics, INC. | $19.70 | 2024 | Daxxify |
| Allergan, INC. | $19.21 | 2021 | |
| Sobi, INC | $16.53 | 2021 | |
| Philips North America LLC | $16.08 | 2021 | |
| Merck Sharp & Dohme LLC | $14.28 | 2021 | |
| Cranial Technologies, INC | $13.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Avalos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.